Session ID: 
ILP13

Transforming Pharma for the Digital Age

1:15pm - 1:45pm Wednesday, March 7
Las Vegas - Venetian Convention Center
Bellini 2105/2106

Description

Digital has already significantly impacted drug development with the adoption of personal health devices for data collection in clinical trials, but pharma has yet to fully embrace the opportunity to use digital for deeper engagement with prescribers and patients. How are pharma companies building their digital organizations and go-to-market strategies for the future?

Speaker(s): 

Managing Partner,
WaveEdge Capital
Executive Director, Digital Health,
Amgen, Inc.
Chief Information Officer,
Johnson & Johnson
VP, Head of Global Digital Health,
Teva Pharmaceuticals

WHERE THE WORLD
CONNECTS FOR HEALTH